Skip

GMO

Americas
Europe, Middle East, Africa
Asia
Australia, New Zealand

Contact Us Log In

Search

Investment Capabilities

Back to main menu

Investment Capabilities

Multi-Asset Class

Document Library

Asset Allocation

Needs-Based Optimization (Nebo)

ETF Investing at GMO

FEATURED PRODUCTS

U.S. Opportunistic Value Strategy

Equities

The GMO U.S. Opportunistic Value Strategy (the “Strategy”) seeks to generate total return by investing primarily in U.S. equities. The Strategy measures its performance against the MSCI U.S. Value Index. GMO’s U.S. Opportunistic ...

Quality Strategy

Equities

The GMO Quality Strategy seeks to generate total return by investing primarily in equities the Focused Equity team believes to be of high quality. The team believes that companies with established track records of historical pro...

GMO Research

Back to main menu

GMO Research

Research Library

GMO Required Reading

Subscribe

POPULAR RESOURCES

GMO Quarterly Letter

7-Year Asset Class Forecast

FEATURED RESEARCH

Beyond the Factor

By Rick Friedman, Catherine LeGraw and John Thorndike

November 05, 2024

GMO has always believed that an objective and disciplined assessment of valuations is critical. We introduce our active, differentiated GMO Value approach, which goes beyond traditional value metrics.

Quality: The Real McCoy

By Kim Mayer

October 29, 2024

With U.S. Quality (QLTY) and International Quality (QLTI) active ETFs available, we revisit why we believe Quality equity can be a core portfolio holding, resilient to economic headwinds and market drawdowns.

ESG Investing

Back to main menu

ESG Investing

Industry Leadership and Collaboration

FEATURED PRODUCTS

Horizons Strategy

Equities

The GMO Horizons Strategy is a global strategy reflecting the view that the world economy is transitioning to a lower carbon future, and that this process will create opportunities for investors to generate excess returns. The Str...

Climate Change Strategy

Equities

The GMO Climate Change Strategy seeks to deliver high total return by investing primarily in equities of companies GMO believes are positioned to benefit, directly or indirectly, from efforts to curb or mitigate the long-term effe...

About GMO

Back to main menu

About GMO

Intermediaries & Wealth Managers

Investment Teams

Firm Management

Relationship Team

Board of Directors

LEADERSHIP SPOTLIGHT

Jeremy Grantham

Long-Term Investment Strategist, Co-Founder

Mr. Grantham co-founded GMO in 1977 and is a member of GMO’s Asset Allocation team, serving as the firm’s long-term investment strategist. He is the Chairman of the GMO Board of Directors, a partner of the firm, and has also served on the investment boards of several non-profit organizations. Prior to GMO’s founding, Mr. Grantham was co-founder of Batterymarch Financial Management in 1969 where he recommended commercial indexing in 1971, one of several claims to being first. He began his investment career as an economist with Royal Dutch Shell. Mr. Grantham earned his undergraduate degree from the University of Sheffield (U.K.) and an MBA from Harvard Business School. He is a member of the Academy of Arts and Sciences, holds a CBE from the UK and is a recipient of the Carnegie Medal for Philanthropy.

Tom Hancock

Head of Focused Equity, Portfolio Manager

Dr. Hancock is the Head of GMO’s Focused Equity team and a portfolio manager for GMO’s Quality Strategies. Dr. Hancock is a partner of the firm. Previously at GMO, he was Co-Head of the Global Equity team. Prior to joining GMO in 1995, he was a research scientist at Siemens and a software engineer at IBM. Dr. Hancock holds BS and MS degrees from Rensselaer Polytechnic Institute and a PhD in Computer Science from Harvard University.

How to Invest

Back to main menu

How to Invest

Americas
Europe, Middle East, Africa
Asia
Australia, New Zealand

Contact Us Log In

Investment Capabilities

Back to main menu

Investment Capabilities

Multi-Asset Class

Document Library

Asset Allocation

Needs-Based Optimization (Nebo)

ETF Investing at GMO

FEATURED PRODUCTS

U.S. Opportunistic Value Strategy

Equities

The GMO U.S. Opportunistic Value Strategy (the “Strategy”) seeks to generate total return by investing primarily in U.S. equities. The Strategy measures its performance against the MSCI U.S. Value Index. GMO’s U.S. Opportunistic ...

Quality Strategy

Equities

The GMO Quality Strategy seeks to generate total return by investing primarily in equities the Focused Equity team believes to be of high quality. The team believes that companies with established track records of historical pro...

GMO Research

Back to main menu

GMO Research

Research Library

GMO Required Reading

Subscribe

POPULAR RESOURCES

GMO Quarterly Letter

7-Year Asset Class Forecast

FEATURED RESEARCH

Beyond the Factor

By Rick Friedman, Catherine LeGraw and John Thorndike

November 05, 2024

GMO has always believed that an objective and disciplined assessment of valuations is critical. We introduce our active, differentiated GMO Value approach, which goes beyond traditional value metrics.

Quality: The Real McCoy

By Kim Mayer

October 29, 2024

With U.S. Quality (QLTY) and International Quality (QLTI) active ETFs available, we revisit why we believe Quality equity can be a core portfolio holding, resilient to economic headwinds and market drawdowns.

ESG Investing

Back to main menu

ESG Investing

Industry Leadership and Collaboration

FEATURED PRODUCTS

Horizons Strategy

Equities

The GMO Horizons Strategy is a global strategy reflecting the view that the world economy is transitioning to a lower carbon future, and that this process will create opportunities for investors to generate excess returns. The Str...

Climate Change Strategy

Equities

The GMO Climate Change Strategy seeks to deliver high total return by investing primarily in equities of companies GMO believes are positioned to benefit, directly or indirectly, from efforts to curb or mitigate the long-term effe...

About GMO

Back to main menu

About GMO

Intermediaries & Wealth Managers

Investment Teams

Firm Management

Relationship Team

Board of Directors

LEADERSHIP SPOTLIGHT

Jeremy Grantham

Long-Term Investment Strategist, Co-Founder

Mr. Grantham co-founded GMO in 1977 and is a member of GMO’s Asset Allocation team, serving as the firm’s long-term investment strategist. He is the Chairman of the GMO Board of Directors, a partner of the firm, and has also served on the investment boards of several non-profit organizations. Prior to GMO’s founding, Mr. Grantham was co-founder of Batterymarch Financial Management in 1969 where he recommended commercial indexing in 1971, one of several claims to being first. He began his investment career as an economist with Royal Dutch Shell. Mr. Grantham earned his undergraduate degree from the University of Sheffield (U.K.) and an MBA from Harvard Business School. He is a member of the Academy of Arts and Sciences, holds a CBE from the UK and is a recipient of the Carnegie Medal for Philanthropy.

Tom Hancock

Head of Focused Equity, Portfolio Manager

Dr. Hancock is the Head of GMO’s Focused Equity team and a portfolio manager for GMO’s Quality Strategies. Dr. Hancock is a partner of the firm. Previously at GMO, he was Co-Head of the Global Equity team. Prior to joining GMO in 1995, he was a research scientist at Siemens and a software engineer at IBM. Dr. Hancock holds BS and MS degrees from Rensselaer Polytechnic Institute and a PhD in Computer Science from Harvard University.

How to Invest

Back to main menu

How to Invest

Search

Strategies

Filter

Alternatives
Multi-Asset Class
Fixed Income
Equities

Asset Allocation Team
Developed Rates & FX Team
Emerging Country Debt Team
Event-Driven Team
Focused Equity Team
Short Duration Strategies Team
Structured Products Team
Systematic Equity Team
Systematic Global Macro Team
Usonian Japan Equity Team

Clear

Additional Content

Document Library

Fixed Income

U.S. Treasury Strategy
Strategy

Disclosures

The account minimums for separately managed accounts implementing GMO’s investment strategies range from $25 to $500 million.

GMO

Copyright © 2024 GMO LLC. All rights reserved.

Terms and Conditions

Benchmark Disclaimers

Legal & Compliance

Web Fraud & Phishing Warning

Investment Capabilities

Research Library

Log In

Copyright © 2024 GMO LLC. All rights reserved.

Terms and Conditions

Benchmark Disclaimers

Legal & Compliance

Web Fraud & Phishing Warning

Leaving GMO?

You are now leaving the GMO website and going to a website that is not operated by GMO. GMO is not responsible for the content on this website.

Continue Cancel